To Top


Richard Snyder, Ph.D.

Dr. Snyder was the founder of Florida Biologix, which was spun out of the University of Florida in 2015 and merged to create Brammer Bio. Dr. Snyder has been investigating virus biology, vector development, cGMP manufacturing and analytical technologies, and viral vector–mediated gene transfer for over 30 years. Dr. Snyder received his doctoral degree in microbiology from The State University of New York at Stony Brook, and obtained his BA in biology from Washington University in St. Louis.

Cell and Gene Therapy

Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing

Cell and Gene Therapy

Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing

Transient Transfection

Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing

Clinical Trials

Investing for Successful Advancement of Viral Vector Manufacturing